Clinical epidemiology of premenstrual disorder: informing optimized patient outcomes

References

• FrankRTThe hormonal causes of premenstrual tensionArch Neur Psych193126510531057
   Google Scholar
• WoodsNFMostADeryGKPrevalene of perimenstrual symptomsAm J Public Health19827211125712646889817
   PubMed Web of Science ®Google Scholar
• Rivera-TovarADFrankELate luteal phase dysphoric disorder in young womenAm J Psychiatry199014712163416362244641
   PubMed Web of Science ®Google Scholar
• JohnsonSRThe epidemiology and social impact of premenstrual symptomsClin Obstet Gynecol19873023673763301135
   PubMed Web of Science ®Google Scholar
• MerikangasKRFoeldenyiMAngstJThe Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort StudyEur Arch Psychiatry Clin Neurosci1993243123328399407
   PubMed Web of Science ®Google Scholar
• RamcharanSLoveEJFickGHGoldfienAThe epidemiology of premenstrual symptoms in a population-based sample of 2,650 urban women: attributable risk and risk factorsJ Clin Epidemiol19924543773921569434
   PubMed Web of Science ®Google Scholar
• NevatteTO’BrienPMBäckströmTConsensus Group of the International Society for Premenstrual DisordersISPMD consensus on the management of premenstrual disordersArch Womens Ment Health201316427929123624686
   PubMed Web of Science ®Google Scholar
• SteinerMStreinerDLSteinbergSThe measurement of premenstrual mood symptomsJ Affect Disord199953326927310404713
   PubMed Web of Science ®Google Scholar
• HalbreichUThe diagnosis of premenstrual syndromes and premenstrual dysphoric disorder – clinical procedures and research perspectivesGynecol Endocrinol200419632033415724807
   PubMed Web of Science ®Google Scholar
• O’BrienPMBäckströmTBrownCTowards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensusArch Womens Ment Health2011141132121225438
   PubMed Web of Science ®Google Scholar
• IsmailKMNevatteTO’BrienSClinical subtypes of core premenstrual disorders: a Delphi surveyArch Womens Ment Health201316319720123292120
   PubMed Web of Science ®Google Scholar
• JahanfarSLyeMSKrishnarajahISThe heritability of premenstrual syndromeTwin Res Hum Genet201114543343621962135
   PubMed Web of Science ®Google Scholar
• DaltonKThe influence of menstruation on health and diseaseProc R Soc Med19645726226414152941
   PubMedGoogle Scholar
• SampsonGAPremenstrual syndrome: a double-blind controlled trial of progesterone and placeboBr J Psychiatry1979135209215385093
   PubMed Web of Science ®Google Scholar
• BäckströmTSandersDLeaskRDavidsonDWarnerPBancroftJMood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndromePsychosom Med19834565035076686333
   PubMed Web of Science ®Google Scholar
• HalbreichUEndicottJGoldsteinSNeeJPremenstrual changes and changes in gonadal hormonesActa Psychiatr Scand19867465765863825581
   PubMed Web of Science ®Google Scholar
• HalbreichUAltIHPaulLPremenstrual changes. Impaired hormonal homeostasisNeurol Clin1988611731943288859
   PubMed Web of Science ®Google Scholar
• SchmidtPJNiemanLKDanaceauMAAdamsLFRubinowDRDifferential behavioral effects of gonadal steroids in women with and in those without premenstrual syndromeN Engl J Med199833842092169435325
   PubMed Web of Science ®Google Scholar
• ChanAFMortolaJFWoodSHYenSSPersistence of premenstrual syndrome during low-dose administration of the progesterone antagonist RU 486Obstet Gynecol1994846100110057970453
   PubMed Web of Science ®Google Scholar
• McEwenBSAlvesSEBullochKWeilandNGOvarian steroids and the brain: implications for cognition and agingNeurology1997485 Suppl 7S8S159153161
   PubMed Web of Science ®Google Scholar
• RapkinAJMorganMGoldmanLBrannDWSimoneDMaheshVBProgesterone metabolite allopregnanolone in women with premenstrual syndromeObstet Gynecol19979057097149351749
   PubMed Web of Science ®Google Scholar
• SmithSSGongQHLiXWithdrawal from 3alpha-OH-5alpha-pregnan-20-One using a pseudopregnancy model alters the kinetics of hippocampal GABAA-gated current and increases the GABAA receptor alpha4 subunit in association with increased anxietyJ Neurosci19981814527552849651210
   PubMed Web of Science ®Google Scholar
• AshbyCRCarrLACookCLSteptoeMMFranksDDAlteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndromeBiol Psychiatry19882422252333390499
   PubMed Web of Science ®Google Scholar
• RapkinAJEdelmuthEChangLCReadingAEMcGuireMTSuTPWhole-blood serotonin in premenstrual syndromeObstet Gynecol19877045335373627623
   PubMed Web of Science ®Google Scholar
• BermanKFSchmidtPJRubinowDRModulation of cognition-specific cortical activity by gonadal steroids: a positron-emission tomography study in womenProc Natl Acad Sci U S A19979416883688419238064
   PubMed Web of Science ®Google Scholar
• RapkinAJBermanSMMandelkernMASilvermanDHMorganMLondonEDNeuroimaging evidence of cerebellar involvement in premenstrual dysphoric disorderBiol Psychiatry201169437438021092938
   PubMed Web of Science ®Google Scholar
• EppersonCNHagaKMasonGFCortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy studyArch Gen Psychiatry200259985185812215085
   PubMed Web of Science ®Google Scholar
• ProtopopescuXTuescherOPanHToward a functional neuroanatomy of premenstrual dysphoric disorderJ Affect Disord20081081–2879418031826
   PubMed Web of Science ®Google Scholar
• ChuongCJCoulamCBKaoPCBergstralhEJGoVLNeuropeptide levels in premenstrual syndromeFertil Steril19854467607652934273
   PubMed Web of Science ®Google Scholar
• ReidRLYenSSPremenstrual syndromeAm J Obstet Gynecol19811391851047006400
   PubMed Web of Science ®Google Scholar
• SteinerMMacdougallMBrownEThe premenstrual symptoms screening tool (PSST) for cliniciansArch Womens Ment Health20036320320912920618
   PubMedGoogle Scholar
• BäckströmTHansson-MalmströmYLindheBACavalli-BjörkmanBNordenströmSOral contraceptives in premenstrual syndrome: a randomized comparison of triphasic and monophasic preparationsContraception19924632532681451521
   PubMed Web of Science ®Google Scholar
• PearlsteinTBBachmannGAZacurHAYonkersKATreatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulationContraception200572641442116307962
   PubMed Web of Science ®Google Scholar
• YonkersKABrownCPearlsteinTBFoeghMSampson-LandersCRapkinAEfficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorderObstet Gynecol2005106349250116135578
   PubMed Web of Science ®Google Scholar
• LopezLMKapteinAAHelmerhorstFMOral contraceptives containing drospirenone for premenstrual syndromeCochrane Database Syst Rev2009CD00658619370644
   PubMed Web of Science ®Google Scholar
• WyattKMDimmockPWIsmailKMJonesPWO’BrienPMThe effectiveness of GnRHa with and without ‘add-back’ therapy in treating premenstrual syndrome: a meta analysisBJOG2004111658559315198787
   PubMed Web of Science ®Google Scholar
• FordOLethabyARobertsHMolBWProgesterone for premenstrual syndromeCochrane Database Syst Rev20123CD00341522419287
   PubMed Web of Science ®Google Scholar
• WatsonNRStuddJWSavvasMGarnettTBaberRJTreatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisteroneLancet1989286657307322570971
   PubMed Web of Science ®Google Scholar
• SchmidtPJNiemanLDanaceauMAEstrogen replacement in perimenopause-related depression: a preliminary reportAm J Obstet Gynecol2000183241442010942479
   PubMed Web of Science ®Google Scholar
• SoaresCNAlmeidaOPJoffeHCohenLSEfficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trialArch Gen Psychiatry200158652953411386980
   PubMed Web of Science ®Google Scholar
• SmithRNStuddJWZambleraDHollandEFA randomised comparison over 8 months of 100 micrograms and 200 micrograms twice weekly doses of transdermal oestradiol in the treatment of severe premenstrual syndromeBr J Obstet Gynaecol199510264754847632640
   PubMedGoogle Scholar
• TellaSHGallagherJCBazedoxifene + conjugated estrogens in HT for the prevention of osteoporosis and treatment of vasomotor symptoms associated with the menopauseExpert Opin Pharmacother201314172407242024093499
   PubMed Web of Science ®Google Scholar
• RapkinAJWinerSAThe pharmacologic management of premenstrual dysphoric disorderExpert Opin Pharmacother20089342944518220493
   PubMed Web of Science ®Google Scholar
• DimmockPWWyattKMJonesPWO’BrienPMEfficacy of selective serotonin-reuptake inhibitors in premenstrual syndrome: a systematic reviewLancet200035692361131113611030291
   PubMed Web of Science ®Google Scholar
• MarjoribanksJBrownJO’BrienPMWyattKSelective serotonin reuptake inhibitors for premenstrual syndromeCochrane Database Syst Rev20136CD00139623744611
   PubMed Web of Science ®Google Scholar
• YonkersKAO’BrienPMErikssonEPremenstrual syndromeLancet200837196191200121018395582
   PubMed Web of Science ®Google Scholar
• FreemanEWSammelMDLinHRickelsKSondheimerSJClinical subtypes of premenstrual syndrome and responses to sertraline treatmentObstet Gynecol201111861293130022105258
   PubMed Web of Science ®Google Scholar
• PearlsteinTBHalbreichUBatzarEDPsychosocial functioning in women with premenstrual dysphoric disorder before and after treatment with sertraline or placeboJ Clin Psychiatry200061210110910732657
   PubMed Web of Science ®Google Scholar
• FreemanEWRickelsKSondheimerSJWittmaackFMSertraline versus desipramine in the treatment of premenstrual syndrome: an open-label trialJ Clin Psychiatry19965717118543554
   PubMed Web of Science ®Google Scholar
• PearlsteinTBStoneABLundSAScheftHZlotnickCBrownWAComparison of fluoxetine, bupropion, and placebo in the treatment of premenstrual dysphoric disorderJ Clin Psychopharmacol19971742612669241004
   PubMed Web of Science ®Google Scholar
• ErikssonEHedbergMAAnderschBSundbladCThe serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndromeNeuropsychopharmacology19951221671767779245
   PubMed Web of Science ®Google Scholar
• CronjeWHVashishtAStuddJWHysterectomy and bilateral oophorectomy for severe premenstrual syndromeHum Reprod20041992152215515229203
   PubMed Web of Science ®Google Scholar
• RossouwJEAndersonGLPrenticeRLWriting Group for the Women’s Health Initiative InvestigatorsRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women’s Health Initiative randomized controlled trialJAMA2002288332133312117397
   PubMed Web of Science ®Google Scholar
• WyattKMDimmockPWJonesPWShaughn O’BrienPMEfficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic reviewBMJ199931871951375138110334745
   PubMed Web of Science ®Google Scholar
• WhelanAMJurgensTMNaylorHHerbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic reviewCan J Clin Pharmacol2009163e407e42919923637
   PubMedGoogle Scholar
• BusseJWMontoriVMKrasnikCPatelis-SiotisIGuyattGHPsychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trialsPsychother Psychosom200978161518852497
   PubMed Web of Science ®Google Scholar
• LustykMKGerrishWGShaverSKeysSLCognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic reviewArch Womens Ment Health2009122859619247573
   PubMed Web of Science ®Google Scholar
• Thys-JacobsSStarkeyPBernsteinDTianJCalcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study GroupAm J Obstet Gynecol199817924444529731851
   PubMed Web of Science ®Google Scholar